Home > Chemicals & Materials > Specialty Chemicals > Custom Synthesis > Polyglycolic Acid Market
The global polyglycolic acid market was valued at USD 9.1 billion in 2024 and is estimated to grow at a CAGR of over 4.5% from 2025 to 2034. The demand for polyglycolic acid (PGA) in medical applications has been rapidly growing due to its high biocompatibility, biodegradability, and versatility, making it ideal for a range of medical and surgical uses. PGA is primarily used in absorbable sutures, providing a reliable solution for internal wound healing without requiring removal after the tissue has healed.
The polymer's predictable degradation rate allows for controlled absorption, making it suitable for applications in complex surgical procedures. Beyond sutures, PGA is increasingly employed in other bioresorbable implants, including tissue scaffolds and fixation devices, supporting tissue regeneration and minimizing long-term implant complications. Additionally, PGA’s usage in drug delivery systems is expanding as it allows for controlled release and eventual breakdown within the body, reducing the need for additional removal procedures. This growing demand across medical applications positions PGA as a critical material in advancing patient care, contributing significantly to the expansion of the market.
Report Attribute | Details |
---|---|
Base Year: | 2024 |
Polyglycolic Acid Market Size in 2024: | USD 9.1 Billion |
Forecast Period: | 2025 to 2034 |
Forecast Period 2025 to 2034 CAGR: | 4.5% |
2034 Value Projection: | USD 14.3 Billion |
Historical Data for: | 2021 – 2024 |
No. of Pages: | 205 |
Tables, Charts & Figures: | 240 |
Segments covered: | Form, Application |
Growth Drivers: |
|
Pitfalls & Challenges: |
|